Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Glucocorticoid-induced Osteoporosis
NCT01465568Phase 4Completed
- Sponsor
- Tuen Mun Hospital
- Start
- Dec 2011
- Primary completion
- Apr 2014
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 4, randomised trial of denosumab in glucocorticoid-induced osteoporosis (GIOP) (2 arms), sponsored by Tuen Mun Hospital. Primary endpoint: bone mineral density changes at the lumbar spine at 12 months. Started Dec 2011; status: completed.
02
Drugs
denosumab
03
Conditions
glucocorticoid-induced osteoporosis (GIOP)
Beyond the preview
Go deeper on NCT01465568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01465568.